US Stock MarketDetailed Quotes

FBIOP Fortress Biotech Inc Series A P

Watchlist
  • 5.250
  • +0.140+2.74%
Close Oct 2 16:00 ET
264.93MMarket Cap0.00P/E (TTM)

Fortress Biotech Inc Series A P Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-14.32%14.9M
4.84%13.03M
11.58%84.51M
21.59%19.95M
110.26%34.75M
-7.94%17.39M
-48.05%12.43M
10.11%75.74M
-10.24%16.4M
-21.61%16.53M
Operating revenue
-13.27%14.9M
5.24%13.03M
-11.05%64.99M
21.93%19.95M
-5.85%15.49M
-8.79%17.18M
-42.21%12.38M
6.22%73.07M
-10.49%16.36M
-21.96%16.46M
Cost of revenue
-15.78%6.54M
5.69%6.82M
-13.37%26.66M
-22.07%6.02M
-10.97%6.43M
1.76%7.77M
-21.38%6.45M
-4.08%30.78M
-18.97%7.72M
-35.34%7.22M
Gross profit
-13.14%8.36M
3.91%6.21M
28.65%57.85M
60.38%13.93M
204.32%28.32M
-14.52%9.62M
-61.96%5.98M
22.51%44.97M
-0.74%8.69M
-6.16%9.31M
Operating expense
-40.80%33.49M
-34.03%42.78M
-19.45%200.2M
-42.06%36.69M
-29.91%42.08M
-9.00%56.58M
2.94%64.85M
15.22%248.53M
-10.50%63.32M
19.36%60.04M
Selling and administrative expenses
-14.80%20.82M
-29.20%17.94M
-17.19%94.12M
-19.81%22.61M
-27.89%21.73M
-15.87%24.44M
-3.54%25.34M
30.88%113.66M
1.81%28.2M
35.63%30.14M
Research and development costs
-60.58%12.67M
-37.13%24.84M
-21.36%106.07M
-59.92%14.08M
-31.95%20.35M
-2.99%32.14M
7.58%39.51M
4.66%134.88M
-18.43%35.12M
6.49%29.9M
Operating profit
46.47%-25.14M
37.88%-36.57M
30.08%-142.34M
58.35%-22.76M
72.88%-13.76M
7.78%-46.96M
-24.53%-58.87M
-13.72%-203.56M
11.88%-54.63M
-25.63%-50.73M
Net non-operating interest income expense
75.69%-1.39M
45.74%-1.77M
-0.56%-12.31M
66.68%-1.35M
33.19%-1.99M
-90.08%-5.71M
-47.64%-3.26M
16.47%-12.24M
29.68%-4.06M
31.03%-2.97M
Non-operating interest income
2.66%734K
-19.59%833K
114.81%3M
2.91%707K
30.55%547K
376.67%715K
629.58%1.04M
115.41%1.4M
377.08%687K
217.42%419K
Non-operating interest expense
-71.34%1.49M
-39.97%1.99M
14.38%11.92M
-49.83%1.52M
-33.89%1.88M
100.31%5.2M
69.30%3.32M
-8.57%10.42M
-16.67%3.02M
-23.76%2.84M
Total other finance cost
-48.41%631K
-37.60%609K
5.43%3.4M
-68.46%544K
18.59%657K
119.57%1.22M
150.90%976K
-17.60%3.23M
-24.71%1.73M
-23.06%554K
Other net income (expense)
65.35%-2.3M
-109.85%-688K
-56.44%1.02M
-365.04%-4.5M
696.60%5.16M
-6.63M
6.98M
-92.00%2.34M
744.87%1.7M
155.57%648K
Gain on sale of security
113.67%70K
-109.99%-667K
291.85%4.42M
---6.28M
--4.54M
---512K
--6.68M
-97.09%1.13M
----
----
Special income (charges)
59.32%-2.65M
----
----
----
--0
---6.51M
----
----
----
--0
-Less:Impairment of capital assets
-15.72%2.65M
----
----
----
--0
--3.14M
----
----
----
--0
-Gain on sale of business
--0
----
----
----
----
---3.37M
----
----
----
----
Other non- operating income (expenses)
-28.61%282K
-106.91%-21K
-380.08%-3.4M
-338.80%-1.35M
-4.32%620K
--395K
--304K
--1.22M
--567K
--648K
Income before tax
51.39%-28.82M
29.24%-39.02M
28.03%-153.63M
49.81%-28.61M
80.05%-10.58M
-9.96%-59.3M
-11.45%-55.15M
-29.88%-213.46M
16.23%-57M
-15.70%-53.06M
Income tax
16.04%521K
-15.59%379K
141K
-5.07%449K
449K
0
Net income
51.39%-28.82M
29.24%-39.02M
27.94%-154.15M
49.54%-28.98M
79.79%-10.72M
-9.96%-59.3M
-11.45%-55.15M
-29.78%-213.91M
16.15%-57.45M
-15.70%-53.06M
Net income continuous Operations
51.39%-28.82M
29.24%-39.02M
27.94%-154.15M
49.54%-28.98M
79.79%-10.72M
-9.96%-59.3M
-11.45%-55.15M
-29.78%-213.91M
16.15%-57.45M
-15.70%-53.06M
Minority interest income
48.22%-17.88M
29.76%-23.61M
26.56%-93.52M
35.39%-19.71M
81.41%-5.68M
-5.99%-34.53M
0.33%-33.61M
-27.18%-127.34M
17.45%-30.5M
-21.81%-30.55M
Net income attributable to the parent company
55.81%-10.95M
28.42%-15.42M
29.96%-60.64M
65.57%-9.28M
77.59%-5.05M
-16.01%-24.78M
-36.66%-21.54M
-33.80%-86.58M
14.63%-26.95M
-8.32%-22.51M
Preferred stock dividends
0.00%2M
-2M
0.00%8.03M
0.00%2.01M
0.00%2.01M
-0.40%2M
8.03M
2.01M
2.01M
Other preferred stock dividends
300.00%400K
-300K
100K
Net income attributable to common stockholders
50.44%-13.34M
24.69%-17.73M
27.42%-68.67M
61.02%-11.29M
71.23%-7.05M
-15.21%-26.92M
-49.40%-23.55M
-46.22%-94.61M
8.27%-28.96M
-17.99%-24.52M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -14.32%14.9M4.84%13.03M11.58%84.51M21.59%19.95M110.26%34.75M-7.94%17.39M-48.05%12.43M10.11%75.74M-10.24%16.4M-21.61%16.53M
Operating revenue -13.27%14.9M5.24%13.03M-11.05%64.99M21.93%19.95M-5.85%15.49M-8.79%17.18M-42.21%12.38M6.22%73.07M-10.49%16.36M-21.96%16.46M
Cost of revenue -15.78%6.54M5.69%6.82M-13.37%26.66M-22.07%6.02M-10.97%6.43M1.76%7.77M-21.38%6.45M-4.08%30.78M-18.97%7.72M-35.34%7.22M
Gross profit -13.14%8.36M3.91%6.21M28.65%57.85M60.38%13.93M204.32%28.32M-14.52%9.62M-61.96%5.98M22.51%44.97M-0.74%8.69M-6.16%9.31M
Operating expense -40.80%33.49M-34.03%42.78M-19.45%200.2M-42.06%36.69M-29.91%42.08M-9.00%56.58M2.94%64.85M15.22%248.53M-10.50%63.32M19.36%60.04M
Selling and administrative expenses -14.80%20.82M-29.20%17.94M-17.19%94.12M-19.81%22.61M-27.89%21.73M-15.87%24.44M-3.54%25.34M30.88%113.66M1.81%28.2M35.63%30.14M
Research and development costs -60.58%12.67M-37.13%24.84M-21.36%106.07M-59.92%14.08M-31.95%20.35M-2.99%32.14M7.58%39.51M4.66%134.88M-18.43%35.12M6.49%29.9M
Operating profit 46.47%-25.14M37.88%-36.57M30.08%-142.34M58.35%-22.76M72.88%-13.76M7.78%-46.96M-24.53%-58.87M-13.72%-203.56M11.88%-54.63M-25.63%-50.73M
Net non-operating interest income expense 75.69%-1.39M45.74%-1.77M-0.56%-12.31M66.68%-1.35M33.19%-1.99M-90.08%-5.71M-47.64%-3.26M16.47%-12.24M29.68%-4.06M31.03%-2.97M
Non-operating interest income 2.66%734K-19.59%833K114.81%3M2.91%707K30.55%547K376.67%715K629.58%1.04M115.41%1.4M377.08%687K217.42%419K
Non-operating interest expense -71.34%1.49M-39.97%1.99M14.38%11.92M-49.83%1.52M-33.89%1.88M100.31%5.2M69.30%3.32M-8.57%10.42M-16.67%3.02M-23.76%2.84M
Total other finance cost -48.41%631K-37.60%609K5.43%3.4M-68.46%544K18.59%657K119.57%1.22M150.90%976K-17.60%3.23M-24.71%1.73M-23.06%554K
Other net income (expense) 65.35%-2.3M-109.85%-688K-56.44%1.02M-365.04%-4.5M696.60%5.16M-6.63M6.98M-92.00%2.34M744.87%1.7M155.57%648K
Gain on sale of security 113.67%70K-109.99%-667K291.85%4.42M---6.28M--4.54M---512K--6.68M-97.09%1.13M--------
Special income (charges) 59.32%-2.65M--------------0---6.51M--------------0
-Less:Impairment of capital assets -15.72%2.65M--------------0--3.14M--------------0
-Gain on sale of business --0-------------------3.37M----------------
Other non- operating income (expenses) -28.61%282K-106.91%-21K-380.08%-3.4M-338.80%-1.35M-4.32%620K--395K--304K--1.22M--567K--648K
Income before tax 51.39%-28.82M29.24%-39.02M28.03%-153.63M49.81%-28.61M80.05%-10.58M-9.96%-59.3M-11.45%-55.15M-29.88%-213.46M16.23%-57M-15.70%-53.06M
Income tax 16.04%521K-15.59%379K141K-5.07%449K449K0
Net income 51.39%-28.82M29.24%-39.02M27.94%-154.15M49.54%-28.98M79.79%-10.72M-9.96%-59.3M-11.45%-55.15M-29.78%-213.91M16.15%-57.45M-15.70%-53.06M
Net income continuous Operations 51.39%-28.82M29.24%-39.02M27.94%-154.15M49.54%-28.98M79.79%-10.72M-9.96%-59.3M-11.45%-55.15M-29.78%-213.91M16.15%-57.45M-15.70%-53.06M
Minority interest income 48.22%-17.88M29.76%-23.61M26.56%-93.52M35.39%-19.71M81.41%-5.68M-5.99%-34.53M0.33%-33.61M-27.18%-127.34M17.45%-30.5M-21.81%-30.55M
Net income attributable to the parent company 55.81%-10.95M28.42%-15.42M29.96%-60.64M65.57%-9.28M77.59%-5.05M-16.01%-24.78M-36.66%-21.54M-33.80%-86.58M14.63%-26.95M-8.32%-22.51M
Preferred stock dividends 0.00%2M-2M0.00%8.03M0.00%2.01M0.00%2.01M-0.40%2M8.03M2.01M2.01M
Other preferred stock dividends 300.00%400K-300K100K
Net income attributable to common stockholders 50.44%-13.34M24.69%-17.73M27.42%-68.67M61.02%-11.29M71.23%-7.05M-15.21%-26.92M-49.40%-23.55M-46.22%-94.61M8.27%-28.96M-17.99%-24.52M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data